Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Debt To Assets Ratio

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Percent.

The item "Debt-To-Assets-Ratio" stands at 32.10 percent as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Debt To Assets Ratio" stands at 32.10 Percent. This represents a decrease of -0.07 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.56 percentage points compared to the value the year prior.
The 1 year change in percentage points is -2.56.
The 3 year change in percentage points is -0.3651.

The Serie's long term average value is 32.53 percent. It's latest available value, on 09/30/2025, is 0.423 percentage points lower, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is +0.639.
The Serie's change in percentage points from it's maximum value, on 09/30/2024, to it's latest available value, on 09/30/2025, is -2.56.

Debt To Assets Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Debt To Assets Ratio905,699,262,464.00
LogoJohnson & Johnson - Debt To Assets Ratio486,508,953,600.00
LogoAbbVie Inc - Debt To Assets Ratio399,570,305,024.00
LogoRoche Holding AG - Debt To Assets Ratio317,433,206,677.55
LogoAstraZeneca PLC - Debt To Assets Ratio280,205,508,085.11